Physician profile
Robert S Taylor
NPI 1003852302
$5,898.74
in general payments reported to CMS, 2019-2025
43 companies · $530 in 2025
The $530 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $329 · 2021: $586 · 2022: $961 · 2023: $1,360 · 2024: $1,380 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,269.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,048.35 | 2019-2025 | Botox, Lupron Depot, Ubrelvy |
| Sumitomo Pharma America, INC. | $800.12 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $798.03 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Myriad Genetic Laboratories, INC. | $431.14 | 2023-2024 | Prolaris |
| Janssen Biotech, INC. | $376.77 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $339.50 | 2019-2024 | Provenge |
| Procept Biorobotics Corporation | $214.34 | 2021-2025 | Aquabeam Robotic System, Aquabeam System |
| Allergan, INC. | $210.46 | 2019-2022 | |
| Urogen Pharma, INC. | $180.21 | 2024-2025 | |
| Antares Pharma, INC. | $168.89 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $120.86 | 2019-2023 | |
| Blue Earth Diagnostics | $100.94 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.37 | 2020-2022 | |
| Hollister Incorporated | $92.63 | 2021-2024 | Infyna Chic |
| Accord Healthcare, INC. | $91.48 | 2022-2024 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.